TRIB - Trinity Biotech plc

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Trinity Biotech reports Q2 results
• Trinity Biotech Q2 2023 Earnings Preview
• Nasdaq notifies Trinity Biotech on minimum bid price non-compliance requirement
• Trinity Biotech GAAP ADS of -$0.152, revenue of $14.83M
• Trinity Biotech Q1 2023 Earnings Preview
• Trinity regains compliance with Nasdaq's listing rule
• Trinity Biotech gets Nasdaq non-compliance notice on minimum bid price requirement
• Trinity BiotechEPS of -$0.27, revenue of $18M in-line
• Trinity Biotech Q4 2022 Earnings Preview
• Trinity Biotech increases loan facility to fund potential acquisitions, ongoing operations
• Trinity Biotech GAAP EPS of -$0.235, revenue of $19.5M
• Trinity Biotech Q3 2022 Earnings Preview
• Trinity Biotech GAAP EPS of -$0.286, revenue of $18.5M
• Trinity Biotech appoints former GE executive Aris Kekedjian as CEO
• Trinity Biotech GAAP EPADS of -50c, revenue of $18.78M misses by $1.22M
• Trinity biotech receives European approval for rapid COVID-19 antigen test
• Trinity Biotech reports Q4 results
• Trinity Biotech jumps 13% after Korea's MiCo acquires stake at premium
• Trinity Biotech wins WHO approval for HIV screening test
• Trinity Biotech closes refinancing transaction to settle debt